As presented in Figure 8, compared to the control group, the expression levels of AURKA, BUB1, CDK1, RAD51, and TOP2A were significantly upregulated in the BA group (P < 0.01), consistent with the bioinformatics analysis. The gene discussed is CDK1; the disease is breast angiosarcoma.